Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research.

Ofili EO, Tchounwou PB, Fernandez-Repollet E, Yanagihara R, Akintobi TH, Lee JE, Malouhi M, Garner ST Jr, Hayes TT, Baker AR, Dent AL 2nd, Abdelrahim M, Rollins L, Chang SP, Sy A, Hernandez BY, Bullard PL, Noel RJ Jr, Shiramizu B, Hedges JR, Berry MJ, Bond VC, Lima MF, Mokuau N, Kirken RA, Cruz-Correa M, Sarpong DF, Vadgama J, Yates C, Kahn SA, Soliman KF, Perry G, Pezzano M, Luciano CA, Barnett ME, Oyekan A, Kumar D, Norris KC; RCMI Investigators and RTRN Team Members.

Ethn Dis. 2019 Feb 21;29(Suppl 1):135-144. doi: 10.18865/ed.29.S1.135. eCollection 2019.

2.

Obstructive sleep apnea in patients with Down syndrome: current perspectives.

Simpson R, Oyekan AA, Ehsan Z, Ingram DG.

Nat Sci Sleep. 2018 Sep 13;10:287-293. doi: 10.2147/NSS.S154723. eCollection 2018. Review.

3.

Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet.

Ozurumba E, Mathew O, Ranganna K, Choi M, Oyekan A.

J Basic Clin Physiol Pharmacol. 2018 Mar 28;29(2):165-173. doi: 10.1515/jbcpp-2017-0074.

PMID:
29500923
4.

Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury.

Alshaman R, Truong L, Oyekan A.

Clin Exp Pharmacol Physiol. 2016 Nov;43(11):1087-1096. doi: 10.1111/1440-1681.12648.

PMID:
27555230
5.

Consenting patients with femoral neck fractures--how well are we involving the patient's relatives?

Qasim SA, Oyekan A, Boyd RP, Kieffer WK, Panose P.

J Perioper Pract. 2016 Jun;26(6):148-52.

PMID:
27498441
6.

The Role of Hypoxia-Inducible Factor/Prolyl Hydroxylation Pathway in Deoxycorticosterone Acetate/Salt Hypertension in the Rat.

Dallatu MK, Nwokocha E, Agu N, Myung C, Newaz MA, Garcia G, Truong LD, Oyekan AO.

J Hypertens (Los Angel). 2014 Dec;3(6). pii: 184.

7.

Renal effects of glucose transporter 4 in Nω-nitro-L-arginine/ /high salt-induced hypertensive rats.

Igbe I, Omogbai EK, Oyekan AO.

Bratisl Lek Listy. 2015;116(1):57-63.

PMID:
25666964
8.

Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.

Rizvi YQ, Mehta CS, Oyekan A.

Vascul Pharmacol. 2013 Nov-Dec;59(5-6):144-51. doi: 10.1016/j.vph.2013.09.001. Epub 2013 Sep 17.

9.

Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal.

Dallatu MK, Choi M, Oyekan AO.

J Hypertens. 2013 Oct;31(10):2043-9. doi: 10.1097/HJH.0b013e32836356a0.

PMID:
23811999
10.

Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics.

Igbe I, Omogbai EK, Oyekan AO.

J Exp Pharmacol. 2013 Apr 4;5:1-13. doi: 10.2147/JEP.S34583. eCollection 2013.

11.

Effects of fenofibrate, a PPAR-α ligand, on the haemodynamics of glycerol-induced renal failure in rats.

Adedapo AA, Oyekan AO.

Hum Exp Toxicol. 2013 Mar;32(3):323-31. doi: 10.1177/0960327112454891. Epub 2012 Aug 2.

PMID:
22859660
12.

Impaired endothelium-dependent and -independent relaxation of aorta from diabetic rats.

Yakubu MA, Sofola OA, Igbo I, Oyekan AO.

Bratisl Lek Listy. 2012;113(2):59-63.

PMID:
22394031
13.

PPARs and their effects on the cardiovascular system.

Oyekan A.

Clin Exp Hypertens. 2011;33(5):287-93. doi: 10.3109/10641963.2010.531845. Epub 2011 Jul 1. Review.

PMID:
21721973
14.

Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.

Fidelis P, Wilson L, Thomas K, Villalobos M, Oyekan AO.

Exp Biol Med (Maywood). 2010 Nov;235(11):1365-74. doi: 10.1258/ebm.2010.009233. Epub 2010 Oct 13.

PMID:
20943934
15.
16.

Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.

Newaz M, Yousefipour Z, Oyekan A.

Ren Fail. 2010 Jan;32(3):384-90. doi: 10.3109/08860221003611745.

PMID:
20370457
17.

Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure.

Yousefipour Z, Oyekan A, Newaz M.

Pharmacol Ther. 2010 Mar;125(3):436-45. doi: 10.1016/j.pharmthera.2009.12.004. Epub 2010 Feb 1. Review.

PMID:
20117134
18.

Effect of peroxisome proliferator-activated receptor-alpha siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet.

Newaz M, Ranganna K, Truong LD, Oyekan A.

J Hypertens. 2009 Nov;27(11):2223-31. doi: 10.1097/HJH.0b013e328330b6d9.

PMID:
19834340
19.
20.

Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice.

Obih P, Oyekan AO.

Blood Press. 2008;17(1):55-63. doi: 10.1080/08037050701789278.

PMID:
18568693
22.

Antioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARgamma gene.

Yousefipour Z, Hercule H, Oyekan AO, Newaz MA.

Ren Fail. 2007;29(7):903-10.

PMID:
17994460
23.
24.
26.

Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent.

Newaz MA, Yousefipour Z, Oyekan A.

J Cardiovasc Pharmacol. 2006 Sep;48(3):88-94.

PMID:
17031261
27.

Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.

Blanton A, Nsaif R, Hercule H, Oyekan A.

J Hypertens. 2006 Sep;24(9):1865-72.

PMID:
16915037
28.

Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.

Newaz M, Yousefipour Z, Oyekan A.

Pharmacol Res. 2006 Sep;54(3):234-40. Epub 2006 May 24.

PMID:
16820301
29.
30.

Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging.

Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, Mu W, Oyekan AO, Johnson RJ.

Kidney Int. 2005 Nov;68(5):2154-63.

31.

NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects.

Newaz M, Blanton A, Fidelis P, Oyekan A.

Mutat Res. 2005 Nov 11;579(1-2):163-71. Epub 2005 Jul 27.

PMID:
16054168
32.

Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat.

Oyekan AO.

J Pharmacol Exp Ther. 2005 Jun;313(3):1289-95. Epub 2005 Mar 15.

PMID:
15769866
33.

Link between free radicals and protein kinase C in glucose-induced alteration of vascular dilation.

Yakubu MA, Sofola OA, Igbo I, Oyekan AO.

Life Sci. 2004 Oct 29;75(24):2921-32.

34.
35.

Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.

Ajayi AA, Ogungbade GO, Hercule HC, Oyekan AO, Mutembei L.

Diabetes Res Clin Pract. 2004 Mar;63(3):155-69.

PMID:
14757287
36.

Endothelin-like action of Pausinystalia yohimbe aqueous extract on vascular and renal regional hemodynamics in Sprague Dawley rats.

Ajayi AA, Newaz M, Hercule H, Saleh M, Bode CO, Oyekan AO.

Methods Find Exp Clin Pharmacol. 2003 Dec;25(10):817-22.

PMID:
14735230
37.

Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats.

Sacerdoti D, Abraham NG, Oyekan AO, Yang L, Gatta A, McGiff JC.

J Pharmacol Exp Ther. 2004 Feb;308(2):636-43. Epub 2003 Nov 4.

PMID:
14600247
38.

Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.

Newaz MA, Yousefipour Z, Hercule H, Truong L, Oyekan A.

Clin Exp Hypertens. 2003 Aug;25(6):335-47.

PMID:
12940471
39.

High salt diet modulates cAMP- and nitric oxide-mediated relaxation responses to isoproterenol in the rat aorta.

Sofola O, Yakubu M, Igbo I, Newaz M, Oyekan A.

Eur J Pharmacol. 2003 Aug 8;474(2-3):241-7.

PMID:
12921869
40.

Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels.

Udosen IT, Jiang H, Hercule HC, Oyekan AO.

Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H2054-63. Epub 2003 Jul 24.

41.

Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat.

Ogungbade GO, Akinsanmi LA, Jiang H, Oyekan AO.

Am J Physiol Renal Physiol. 2003 Nov;285(5):F955-64. Epub 2003 Jul 15.

42.
43.

Cytochrome P450 arachidonic acid metabolites modulate renal tubular function.

Carroll MA, Ferreri NR, Escalante BA, Oyekan AO, McGiff JC.

Adv Exp Med Biol. 2003;525:67-9. No abstract available.

PMID:
12751738
46.

Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat.

Oyekan A.

Clin Exp Pharmacol Physiol. 2002 Nov;29(11):990-5.

PMID:
12366390
47.
48.

Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension.

Newaz MA, Yousefipour Z, Oyekan A.

Blood Press. 2002;11(2):110-5.

PMID:
12035871
49.

Contribution of renal oxygenases to glycerol-induced acute renal failure in the rat.

Newaz MA, Oyekan AO.

J Cardiovasc Pharmacol. 2002 Jun;39(6):834-41.

PMID:
12021577
50.

Supplemental Content

Loading ...
Support Center